NeuroMetrix, Inc. (NASDAQ:NURO) Sees Large Increase in Short Interest

NeuroMetrix, Inc. (NASDAQ:NURO) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 28,100 shares, a growth of 24.3% from the August 15th total of 22,600 shares. Currently, 1.8% of the shares of the stock are sold short. Based on an average trading volume of 15,200 shares, the short-interest ratio is currently 1.8 days.

NeuroMetrix Stock Up 0.7 %

NASDAQ:NURO traded up $0.03 on Tuesday, reaching $4.05. 19,001 shares of the company’s stock were exchanged, compared to its average volume of 27,372. NeuroMetrix has a 52-week low of $2.66 and a 52-week high of $6.00. The business has a fifty day moving average of $3.61 and a 200-day moving average of $3.84. The firm has a market capitalization of $8.14 million, a price-to-earnings ratio of -0.64 and a beta of 2.28.

NeuroMetrix (NASDAQ:NURO) last announced its quarterly earnings data on Tuesday, August 6th. The medical device company reported ($0.74) earnings per share for the quarter. The firm had revenue of $0.77 million during the quarter. NeuroMetrix had a negative net margin of 181.04% and a negative return on equity of 41.74%.

Analyst Upgrades and Downgrades

Separately, StockNews.com initiated coverage on shares of NeuroMetrix in a research report on Tuesday. They set a “sell” rating for the company.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.